Ranexa (Ranolazine) – Patient Information

Ranexa contains ranolazine, a medicine used to help control symptoms of chronic (long-term) angina—commonly chest pain or discomfort that happens when the heart muscle needs more oxygen than it can receive. Ranexa is designed for people who continue to have angina despite other treatments, or who cannot tolerate certain older medicines.

This guide is written to be patient-friendly and focused on how Ranexa works, what to expect, and how to use it safely. Always follow the dosing instructions from your healthcare professional and read the consumer medicine information (CMI) provided with your medicine.

Quick Facts

• Active ingredient: Ranolazine
• Medicine type: Anti-anginal (helps prevent or reduce chest pain)
• Common form: Extended-release tablets (often taken twice daily)
• Primary benefit: Reduces frequency of angina attacks in chronic angina
• Not for immediate relief: Not intended to stop an attack already in progress

What is Ranexa used for?

In Australia, Ranexa is used for the treatment of chronic angina in adults. It may be prescribed when:

• Angina symptoms persist despite other anti-anginal therapies, or
• There are reasons some other anti-anginal medicines are not suitable.

Ranexa helps improve exercise tolerance and reduces angina frequency for many patients. Individual response varies.

How Ranexa works (Mechanism of Action)

Ranolazine works differently from many other angina medicines. Its key action is on the heart’s electrical and energy-handling pathways.

In simple terms:

• Ranolazine inhibits late sodium (Na+) current in heart cells.
• This reduces abnormal sodium build-up, which can indirectly help control calcium (Ca2+) handling.
• The net effect is improved heart cell efficiency, which can reduce angina symptoms.

Ranolazine does not primarily work by lowering heart rate or blood pressure, which is one reason it may be useful for some people who cannot tolerate those effects.

Pharmacokinetics (How the body processes it)

Understanding pharmacokinetics can help you know when to expect benefits and why consistent dosing matters.

Typical use and timing

Ranexa is generally taken twice daily in fixed doses (for example, 500 mg or 1000 mg tablets, depending on the product strength and your treatment plan).

When should I take it?

• Try to take Ranexa at roughly the same times each day (e.g., morning and evening).
• You may choose times that suit your routine, such as with breakfast and dinner.
• If you miss a dose, take it when you remember unless it’s near the time of the next dose. Do not double up.

How soon does it work?

Some people notice fewer angina episodes after the first days, but more consistent benefits are often seen after 1–2 weeks (and sometimes longer) as steady levels build and your body adjusts.

Ranexa helps prevent or reduce chest pain. It is not designed to treat a sudden angina attack already in progress. If you experience chest pain, use the acute rescue plan provided by your healthcare professional (commonly a fast-acting nitroglycerin/similar strategy where appropriate).

Food interactions and taking with meals

Food effects are generally less of an issue with extended-release products than with many immediate-release medicines, but consistent use helps reduce variability.

With or without food?

• Ranexa can typically be taken with or without food.
• If you find it upsets your stomach, taking it with meals may be more comfortable.
• Avoid large swings in meal patterns (e.g., very irregular meal timing) if you notice symptom changes.

Grapefruit and other strong CYP3A inhibitors

Because ranolazine is processed by CYP3A, certain foods and drinks that strongly affect CYP3A enzymes can raise ranolazine levels.

• Grapefruit/grapefruit juice may increase ranolazine exposure.
• It is best to avoid grapefruit products unless your healthcare professional specifically confirms it is safe.

Alcohol and medicine interactions

Alcohol can worsen dizziness, fatigue, and nausea in some people. It may also affect how you feel your heart is working, which can be confusing if you’re monitoring angina symptoms.

Alcohol

• If you choose to drink alcohol, do so cautiously and in moderation.
• Stop drinking and seek advice if you notice worsening dizziness, faintness, palpitations, or unusual side effects.

Medicine interactions (important)

Ranexa has meaningful interactions due to liver metabolism and effects on heart electrical activity (specifically the QT interval). Please take extra care with medications that: increase ranolazine levels or also affect QT.

• Strong CYP3A inhibitors (may significantly increase ranolazine):
  • Some antifungals (e.g., ketoconazole, itraconazole)
  • Some antibiotics (e.g., clarithromycin)
  • Some HIV medicines (protease inhibitors in certain regimens)
• Other QT-prolonging medicines may raise the risk of rhythm changes.
• Medicines that affect metabolism (CYP3A/CYP2D6) can alter exposure.

This is not a complete interaction list. Always provide your full medication list to your healthcare professional and your pharmacist, including non-prescription products and supplements.

Indications (When doctors consider Ranexa)

Ranexa is indicated for chronic angina in adults as part of a treatment strategy. It is used to:

• Decrease the frequency of angina attacks
• Improve exercise tolerance
• Provide additional symptom control alongside other anti-anginal medicines when needed

It may be used alone in selected circumstances or with other angina medicines such as beta-blockers, calcium channel blockers, or nitrates, depending on your clinical situation.

Dosing guidance (general information)

Dosage depends on your age, kidney and liver function, other medicines, and response to treatment. Below is general information; your exact dose should follow your prescribing plan.

Common starting approach

• Treatment often starts at a lower dose to reduce the chance of side effects, then adjusted based on symptom control and tolerability.
• Ranexa is usually taken twice daily.

Typical dose strengths

Ranexa is available in extended-release tablet strengths (commonly 500 mg and 1000 mg). The prescribed strength and whether you step up gradually should be confirmed by your healthcare professional.

How to take extended-release tablets

• Swallow tablets whole. Do not crush, split, or chew unless your medicine information specifically says you can (most extended-release tablets must be swallowed whole).
• Keep a consistent routine to maintain stable blood levels.

Missed dose

• Take the missed dose as soon as you remember if it’s not close to the next scheduled dose.
• If it is near the next dose, skip the missed dose.
• Do not double to make up for the missed dose.

Stopping suddenly

Do not stop Ranexa abruptly without medical advice. If you need to stop, your healthcare professional can advise the safest approach. Stopping may lead to a return of angina symptoms.

Safety profile and side effects

Like all medicines, Ranexa can cause side effects. Many are mild and improve as your body adjusts. Because ranolazine can affect heart electrical conduction (QT interval), your healthcare professional may monitor for rhythm-related risk, especially if you have other contributing factors or interacting medicines.

Common side effects

• Dizziness
• Headache
• Nausea
• Constipation
• Weakness or tiredness
• Sometimes light-headedness

Serious or urgent symptoms (seek medical help)

Contact urgent medical services or seek urgent care if you experience:

• Fainting or severe dizziness
• Symptoms of abnormal heart rhythm (e.g., fast, irregular heartbeat, severe palpitations)
• Severe shortness of breath or chest pain that does not match your usual pattern
• Allergic reaction signs such as swelling of face/lips, rash with breathing difficulty

Risk factors that may increase side effects

Certain conditions and situations can make Ranexa less suitable or require closer monitoring:

• Liver impairment
• Kidney impairment (may affect dosing and monitoring)
• Use of medicines that increase ranolazine exposure or affect QT interval
• Electrolyte disturbances (for example low potassium or magnesium)
• A personal history of rhythm problems or relevant heart conditions

Practical use tips

• Use a pill organiser or phone reminders to help keep timing consistent.
• Track your angina: note frequency, triggers, and how well Ranexa is helping. Bring this to reviews.
• Monitor new side effects: if dizziness or nausea is new or worsening, speak with a pharmacist or healthcare professional.
• Tell clinicians about all medicines: include prescriptions, over-the-counter products, vitamins, herbal supplements, and “as needed” drugs.
• Watch for QT-risk combinations: avoid starting new medicines without checking interactions.
• Stay hydrated and maintain electrolyte balance where relevant (especially if you have vomiting/diarrhoea).

Alternative options for chronic angina

Treatment for chronic angina is individual. Depending on your symptoms and health conditions, alternatives may include:

• Beta-blockers (e.g., metoprolol, bisoprolol) – help reduce heart workload
• Calcium channel blockers (e.g., amlodipine, diltiazem) – improve blood flow and reduce spasm
• Nitrates (short-acting for rescue, longer-acting for prevention)
• Other anti-anginal medicines as appropriate
• Risk-factor management (statins, lifestyle changes) to reduce cardiovascular risk

Your healthcare professional may also consider investigations or referral options if angina remains uncontrolled. Never change or stop any medicine without advice.

Market and legal context for Australia

In Australia, Ranexa is supplied under the national medicines framework and is typically categorised as a prescription-only medicine at the time of publication. Availability, supply processes, and required documentation may vary across pharmacies and online services.

To ensure safe supply, Australian pharmacies generally apply standard checks to:

• Confirm correct product and strength
• Reduce risk from interacting medicines
• Confirm identity and delivery details
• Comply with relevant state and national pharmacy regulations

Recent guidance and monitoring (general)

While guidance can change over time, ongoing clinical practice commonly includes:

• Reviewing the full medication list for interaction risk (especially CYP3A inhibitors and QT-prolonging medicines)
• Considering baseline and follow-up ECG in people at higher risk, such as those with arrhythmia history, significant comorbidities, or interacting medicines
• Periodic assessment of kidney and liver function where relevant
• Titrating dose based on symptom control and side effects

For the most accurate and up-to-date information for your situation, speak with your pharmacist or healthcare professional.

Delivery and availability (online pharmacy)

Ranexa availability can vary by stock levels and strength. Most online pharmacies provide:

• Clear product listings showing the strength (e.g., 500 mg vs 1000 mg) and pack size
• Estimated delivery times during checkout
• Delivery options depending on your location
• Support from a pharmacist for questions about use and interactions

If you have urgent needs for your angina management, contact the pharmacy support team before placing an order, as processing and shipping times can differ.

FAQ

1) Is Ranexa the same as nitroglycerin?

No. Ranexa (ranolazine) is a preventive medicine for chronic angina symptoms. Nitroglycerin (or similar rescue therapies) is typically used for quicker relief during an angina attack. Ranexa is not intended to stop an attack that is already happening.

2) Can I take Ranexa if I have chest pain right now?

Ranexa is not designed for immediate relief of sudden chest pain. If you experience chest pain, follow your agreed action plan (including any rescue medication provided) and seek urgent medical attention if symptoms are severe, new, worsening, or different from usual.

3) How long until I feel a difference?

Many people notice improvements within days, but more stable benefits often take around 1–2 weeks. Keep taking it as prescribed unless advised otherwise.

4) What should I do if I miss a dose?

Take the missed dose when you remember if it’s not close to the next dose. Otherwise, skip it and continue with your next scheduled dose. Don’t double up.

5) Can I drink alcohol while taking Ranexa?

Moderate alcohol may be okay for some people, but alcohol can worsen dizziness or fatigue. If you notice side effects, avoid alcohol and talk to your pharmacist or healthcare professional.

6) Are there foods I should avoid?

Grapefruit and grapefruit juice can increase ranolazine levels due to CYP3A effects, so it’s generally best to avoid them unless your clinician confirms otherwise. Taking with meals is usually fine; consistency matters.

7) What drug interactions are most concerning?

Medicines that strongly inhibit CYP3A can raise ranolazine levels, and medicines that also affect heart rhythm (QT interval) may increase risk. Always check interactions with your pharmacist and provide a complete list of medicines and supplements.

8) Will Ranexa lower my blood pressure or heart rate?

Ranolazine is not primarily used to lower heart rate or blood pressure. However, some people do experience dizziness or weakness, so monitoring how you feel is important, especially when starting or changing doses.

9) Is Ranexa safe for everyone?

Not necessarily. Safety depends on individual health factors—particularly liver/kidney function, electrolyte status, and other medications. People at higher risk of QT-related issues may need additional monitoring or alternative therapies.

10) What should I tell my pharmacist before starting Ranexa?

Tell them about:

• Your full medication list (including over-the-counter and supplements)
• Any history of heart rhythm problems
• Liver or kidney problems
• Any recent fainting, severe dizziness, or palpitations
• Any planned new medicines (including antibiotics or antifungals)

References and responsible use

Product information can change. For the most accurate details about your specific brand, strength, and dosing, refer to the consumer medicine information supplied with your medicine, and consult a pharmacist or healthcare professional.